Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 15 Life Science Startup Investors in Sweden

Last updated: Aug 2024 A list of 15 angel investors and VC funds that invest in Life science startups based in Sweden. We rank investors based on the number of investments they made in Life science companies from Sweden. We update this investor list every month.

Top 15 Life Science Startup Investors in Sweden

Investor	Life Science Sweden investments
Crowberry Capital	3
Inventure	3
Noaber	2
Norrsken VC	2
CBC Investment Group	1
Per Båtelson	1
Almi Invest	1
SEB Venture Capital	1
Hampus Jakobsson	1
Unruly Capital	1
Industrifonden	1
Sofinnova Partners	1
HealthCap	1
Josefin Landgård	1
Erik Byrenius	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.

Investment focus

Software, Information Technology, Gaming
Seed, Series A, Pre-Seed
Iceland, Denmark, Finland

Portfolio highlights

Saidot — Saidot is a governance tool for safe, ethical and transparent AI.
Social First — We create games that are social experiences, span decades and extend beyond gaming; giving our players platforms to create meaningful relationships with people all across the world.
Scaleup Finance — Improve your financial management

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Series B
Finland, Sweden, Denmark

Portfolio highlights

Leya AI — Feel and sound like an English native in 3 months
Steep — Business intelligence for modern companies. Steep lets anyone on your team stay on top of your data.
Reveel — Say goodbye to paper maps, brochures, and outdated audio guides. Reveel offers digital solutions for destinations such as UNESCO sites, sights, museums, cities, hotels and parks, taking the visitor experience to the next level. Become part of the smart destination movement, enhance the visitor experience, and discover the future of travel.

Noaber Ventures invests in initiatives that bring social transformations using information technology.

Investment focus

Health Care, Medical, Fitness
Seed, Series A, Funding Round
The Netherlands, Israel, Sweden

Portfolio highlights

Newsenselab (M-sense) — M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Alba Health — Discover your baby's gut health & microbiome for the best start in life.

We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.

Investment focus

Software, Health Care, Food and Beverage
Seed, Series A, Funding Round
Sweden, United Kingdom, Germany

Portfolio highlights

Cellcolabs — Cellcolabs provides high quality stem cells at competitive prices for use within research and treatments.
Fever — Grid balancing to enable more re-newables
Startbutton — We help multi-national businesses sell products and get paid in African countries in a compliant and tax-efficient manner, without the need to register locally.

CBC Investment Group started in 2009 in the midst of the financial crisis. The banks were on their knees, start-ups of small and medium-sized companies - all of a sudden they saw their credit and credit promises turned into demands for quick repayment and empty words. Serious talented entrepreneurs' ideas and companies risked going completelyunnecessary. In response to this crisis, they started the CBC Investment Group.

Investment focus

Biotechnology, Software, SaaS
Funding Round, Seed, Series B
Sweden, Denmark, Germany

Portfolio highlights

GLX Analytix — GLX Analytix is a biomedical company that develops a new technology to identify a biomarker. The company was founded in 2019 and is based in Copenhagen, Denmark.
Swiftly — World's first AI that applies for jobs. Say goodbye to creating CV's, searching and applying for jobs. Let Swiftly do it for you! Welcome to the new age.
Hugel Control — HUGEL, Inc. strives to be a global company that continuously creates innovative products, promotes universal health, and improves the quality of life through state-of-the-art technology and creativity.

Per Båtelson

Investment focus

Medical, Health Care, Medical Device
Seed, Angel, Funding Round
Sweden, United States

Portfolio highlights

Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Valar Labs — AI to Make Oncologists Smarter
Imaginecare — Imaginecare is a self-care support that helps patients with long-term health challenges to a better life. Imaginecare consists of a technical platform supplemented with a range of services and analysis tools that together offer a complete solution for healthcare.

ALMI Invest is a venture capital company which invests in Swedish companies with exciting, scalable business models and motivated entrepreneurs. ALMI Invest consists of eight regionally based venture capital funds, all with local offices and experienced local investment managers. We manage a total of SEK 1 billion. Unlike most venture capitalists,we can invest in a wide range of businesses. A strong team of entrepreneurs, a scalable business model and an initial revenue stream are more important than the line of business when we invest.Our first, initial investment would typically be SEK 2-4 million. During the lifetime of an investment, sums of up to SEK 10 million can be ventured. We always syndicate with an investment partner (another venture capitalist or angel investor) from Sweden or otherwise which means that we can take a maximum of 50 percent of an investment round.ALMI Invest was founded in 2009 by ALMI Fretagspartner together with regional investors. Half of our capital comes from European Union structural funds, which accounts for an investment of SEK 500 million. The other 50 per cent comes from regional investors and ALMI Fretagspartner.

Investment focus

Software, Health Care, Information Technology
Funding Round, Seed, Pre-Seed
Sweden, United States, United Kingdom

Portfolio highlights

RemotiveLabs — RemotiveLabs is a developer of an automotive software development platform designed to streamline the vehicle manufacturing process.
GAIA BioMaterials — GAIA BioMaterials is the manufacturer of a bio-degradable product that offers pouch, tray, and bottle products.
Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.

SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.

Investment focus

Software, Information Technology, Financial Services
Funding Round, Series A, Series B
Sweden, Denmark, United Kingdom

Portfolio highlights

Airsonett — Research-based medical technology company which leads the way in the development of non-pharmaceutical treatment for allergic asthma.
EnginZyme — EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide.
Qvantum — Qvantum is driven by a passion for a sustainable future and we are changing the way the cities of Europe are heated.

Hampus Jakobsson is a General Partner at early stage climate tech venture fund Pale Blue Dot.Prior to co-founding Pale Blue Dot, Hampus was a Venture Partner at science fund Blue Yard and a prolific angel investor with >100 angel investments. He co-founded of The Astonishing Tribe (acquired by Blackberry in 2010 for $150m). He left Blackberry2012 to found Brisk.io a sales productivity tool which folded 2016.

Investment focus

Health Care, Software, Mobile
Seed, Angel, Series A
Sweden, Denmark, United States

Portfolio highlights

ClimateView — ClimateView is a Swedish climate action technology company that helps cities transform climate planning into progress. We combine data, agent-based modelling and interface design to help cities successfully manage the transition to zero carbon economies.
Mojo — Laboratory-grade AI-powered semen test at home. Test your sperm count, motility, volume and concentration with the Mojo kit. Check your fertility from home at low cost.
Volta Greentech — Battling global warming by reducing methane emissions from cows

Investing in the crazy before it becomes normal

Investment focus

Biotechnology, Environmental Engineering, Environmental Consulting
Seed, Pre-Seed
United Kingdom, United States, France

Portfolio highlights

4QT — Cleantech, Construction, Electrification
Kateri — Kateri is a carbon producer that helps to unlock the potential of grasslands to sequester carbon.
Volteras — Volteras collects, standardizes, and optimizes data from hundreds of energy devices into a single data model. Volteras Connect enables businesses to use this data to produce new revenue streams, reduce costs, and create new business models. It aspires to be the link between electric vehicles and anything they may come into contact with, fromchargers and house batteries to energy suppliers and mapping software.

Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.

Investment focus

Software, Biotechnology, Information Technology
Funding Round, Series A, Seed
Sweden, United States, Denmark

Portfolio highlights

Arevo — Arevo offers liquid and granular amino acid fertilizer technologies for faster and better plant establishment.
Telness Tech — We help telcos maximize customer happiness and minimize OPEX through automation. Our proprietary, cloud-based, end-to-end BSS/OSS platform is connectivity ready in 64 countries.
ZeroPoint Technologies — ZeroPoint Technologies AB was created in 2016 as a spinout from Chalmers University of Technology. The Intellectual Property Portfolio related to computer memory management was the acquired from the University and transferred into a new startup.The Technology, ideas and many of the people behind and with ZeroPoint comes from Professor PerStenströms research group, which is internationally recognized for excellence within high-performance Computing. Since its creation, ZeroPoint has attracted skilled people from industry, finance and the startup community and raised its’ first round of Venture Capital in 2016.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

deepc — The Radiology AI Platform - Your effortless access to AI
Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United States, Sweden, France

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.

Josefin Landgård is the Founder and CEO of Mantle. Previously she served as the Co-Founder and COO at KRY back in March 2014 to September 2018.

Investment focus

Health Care, Medical, Women's
Seed, Angel, Pre-Seed
Sweden, France

Portfolio highlights

Estmn — Estrid is an online portal that offers women's personal care products.
Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.

Erik Byrenius is a founding partner of Mudcake, a microfund run by ex-founders dedicated to making the world a better place for the next generation. We invest in the strongest founders shaping the way we produce, distribute and consume food. Our typical ticket is $200k-$600k in pre-seed and seed rounds globally.Previously he was the CEO andco-founder of food delivery business OnlinePizza (exit to Delivery Hero), founder of StartupTools and co-founded the angel syndicate Nordic Makers.

Investment focus

Health Care, Security, Information Technology
Seed, Angel, Pre-Seed
Sweden, United States, Denmark

Portfolio highlights

Digitail — Grow your practice, offer a modern client experience, and automate routine practice tasks with the proven all-in-one veterinary software.
Mavenoid — Mavenoid is the only product support automation platform built for complex products and devices. Using our unique AI, we solve problems too complex for chatbots
Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.

Investors by industry

Media (entertainment)

Hardware

Proptech

Marketplace